Cargando…

Using Real-World Data to Determine Health System Costs of Ontario Women Screened for Breast Cancer

Our study was to determine breast cancer screening costs in Ontario, Canada for screenings conducted through a formal (Ontario Breast Screening Program, OBSP) and informal (non-OBSP) screening program using administrative databases. Included women were 49–74 years of age when receiving screening mam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mittmann, Nicole, Seung, Soo Jin, Diong, Christina, Gatley, Jodi M., Wolfson, Michael, Guertin, Marie-Hélène, Pashayan, Nora, Simard, Jacques, Chiarelli, Anna M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689006/ https://www.ncbi.nlm.nih.gov/pubmed/36354717 http://dx.doi.org/10.3390/curroncol29110657

Ejemplares similares

Healthcare and Cancer Treatment Costs of Breast Screening Outcomes among Higher than Average Risk Women
por: Mittmann, Nicole, et al.
Publicado: (2023)

Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada
por: Dai, Wei Fang, et al.
Publicado: (2020)

Impact of smoking on health system costs among cancer patients in a retrospective cohort study in Ontario, Canada
por: Isaranuwatchai, Wanrudee, et al.
Publicado: (2019)

Potential of polygenic risk scores for improving population estimates of women’s breast cancer genetic risks
por: Wolfson, Michael, et al.
Publicado: (2021)

Examining Treatment Patterns and Real-World Outcomes in Chronic Lymphocytic Leukemia Using Administrative Data in Ontario
por: Seung, Soo Jin, et al.
Publicado: (2021)

Real-world treatment patterns and survival outcomes for treated biliary tract cancer patients using administrative databases in Ontario
por: Seung, Soo Jin, et al.
Publicado: (2023)

Examination of Trends in Diabetes Incidence Among Children During the COVID-19 Pandemic in Ontario, Canada, From March 2020 to September 2021
por: Shulman, Rayzel, et al.
Publicado: (2022)

Incremental healthcare utilisation and costs among new senior high-cost users in Ontario, Canada: a retrospective matched cohort study
por: Muratov, Sergei, et al.
Publicado: (2019)

Acute Care Visits for Assault and Maltreatment Before vs During the COVID-19 Pandemic in Ontario, Canada
por: Saunders, Natasha, et al.
Publicado: (2021)

Should Age-Dependent Absolute Risk Thresholds Be Used for Risk Stratification in Risk-Stratified Breast Cancer Screening?
por: Pashayan, Nora, et al.
Publicado: (2021)

2369. Prescribing Choices and C. difficile Infection Risk: A Longitudinal Cohort Study of Nursing Home Residents in Ontario, Canada
por: Antoine. Brown, Kevin, et al.
Publicado: (2019)

Cost‐effectiveness of second‐line ipilimumab for metastatic melanoma: A real‐world population‐based cohort study of resource utilization
por: Lu, Brandon, et al.
Publicado: (2023)

Economic evaluation of smoking cessation in Ontario's regional cancer programs
por: Djalalov, Sandjar, et al.
Publicado: (2018)

Mortality in older adults following a fragility fracture: real-world retrospective matched-cohort study in Ontario
por: Brown, Jacques P., et al.
Publicado: (2021)

Improving the efficiency of cost-effectiveness analysis to inform policy decisions in the real world: lessons from the Pharmacoeconomics Research Unit at Cancer Care Ontario
por: Hoch, Jeffrey S
Publicado: (2014)

Real-World Cost-Effectiveness of First-Line Gemcitabine Plus Nab-Paclitaxel vs FOLFIRINOX in Patients With Advanced Pancreatic Cancer
por: Arciero, Vanessa, et al.
Publicado: (2022)

Changes in healthcare costs and survival in the era of immunotherapy and targeted systemic therapy for melanoma.
por: Nguyen, Paul, et al.
Publicado: (2022)

A Systematic Review and Critical Assessment of Breast Cancer Risk Prediction Tools Incorporating a Polygenic Risk Score for the General Population
por: Mbuya-Bienge, Cynthia, et al.
Publicado: (2023)

Fragility fracture identifies patients at imminent risk for subsequent fracture: real-world retrospective database study in Ontario, Canada
por: Adachi, Jonathan D., et al.
Publicado: (2021)

Palivizumab’s real-world effectiveness: a population-based study in Ontario, Canada, 1993–2017
por: Fitzpatrick, Tiffany, et al.
Publicado: (2021)

Desires, Need, Perceptions, and Knowledge of Assisted Reproductive Technologies of HIV-Positive Women of Reproductive Age in Ontario, Canada
por: Zhang, Yimeng, et al.
Publicado: (2012)

Cost-effectiveness of primary offer of IVF vs. primary offer of IUI followed by IVF (for IUI failures) in couples with unexplained or mild male factor subfertility
por: Pashayan, Nora, et al.
Publicado: (2006)

The Variations in Care and Real-world Outcomes in Individuals With Rectal Cancer: Protocol for the Ontario Rectal Cancer Cohort
por: Patel, Sunil, et al.
Publicado: (2022)

Prevalence, Cost, and Variation in Cost of Pediatric Hospitalizations in Ontario, Canada
por: Gill, Peter J., et al.
Publicado: (2022)

Ontario and New Zealand Pharmaceuticals: Cost and Coverage
por: Kelley, Leah T., et al.
Publicado: (2018)

Implementing wait-time reductions under Ontario government benchmarks (Pay-for-Results): a Cluster Randomized Trial of the Effect of a Physician-Nurse Supplementary Triage Assistance team (MDRNSTAT) on emergency department patient wait times
por: Cheng, Ivy, et al.
Publicado: (2013)

Cost-Effectiveness Analysis of Fosfomycin for Treatment of Uncomplicated Urinary Tract Infections in Ontario
por: Perrault, Louise, et al.
Publicado: (2017)

Integration of real-world evidence from different data sources in health technology assessment
por: Graili, Pooyeh, et al.
Publicado: (2023)

Antibiotic susceptibility of urine culture specimens in Ontario: a population-based cohort study
por: Marchand-Austin, Alex, et al.
Publicado: (2022)

Regional variation in healthcare spending and mortality among senior high-cost healthcare users in Ontario, Canada: a retrospective matched cohort study
por: Muratov, Sergei, et al.
Publicado: (2018)

Real world, big data cost of pharmaceutical treatment for rheumatoid arthritis in Greece
por: Souliotis, Kyriakos, et al.
Publicado: (2019)

Cost effectiveness of the NHS breast screening programme: life table model
por: Pharoah, Paul D P, et al.
Publicado: (2013)

A retrospective analysis of real-world use of the eaTracker® My Goals website by adults from Ontario and Alberta, Canada
por: Lieffers, Jessica R. L., et al.
Publicado: (2016)

Incidence and real-world burden of brain metastases from solid tumors and hematologic malignancies in Ontario: a population-based study
por: Habbous, Steven, et al.
Publicado: (2020)

Real-Time Surveillance for Respiratory Disease Outbreaks, Ontario, Canada
por: van Dijk, Adam, et al.
Publicado: (2009)

Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation (PERSPECTIVE I&I)
por: Brooks, Jennifer D., et al.
Publicado: (2021)

Direct cost associated with acquired brain injury in Ontario
por: Chen, Amy, et al.
Publicado: (2012)

Cost of Futile ICU Care in One Ontario Hospital
por: Schouela, Nicholas, et al.
Publicado: (2021)

The cost-effectiveness of risk-stratified breast cancer screening in the UK
por: Hill, Harry, et al.
Publicado: (2023)

Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model
por: Pashayan, Nora, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jmh833oidcc3f4u7th7qef33mv